4//SEC Filing
HORAK IVAN D 4
Accession 0000930413-11-002544
CIK 0000727510other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:04 PM ET
Size
9.0 KB
Accession
0000930413-11-002544
Insider Transaction Report
Form 4
HORAK IVAN D
EVP, R&D, Chief Scientific Off
Transactions
- Tax Payment
Common Stock
2011-04-03$11.02/sh−9,380$103,368→ 138,476 total - Exercise/Conversion
Common Stock
2011-04-03+26,480→ 147,856 total - Exercise/Conversion
Restricted Stock Units
2011-04-03−16,800→ 0 totalExercise: $0.00From: 2011-04-03Exp: 2011-04-03→ Common Stock (16,800 underlying)
Footnotes (2)
- [F1]Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock.
- [F2]The Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock units described in this Form 4.
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeother
Related Parties
1- filerCIK 0001247903
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:04 PM ET
- Size
- 9.0 KB